Derik De Bruin
Stock Analyst at B of A Securities
(4.96)
# 24
Out of 4,876 analysts
217
Total ratings
64.38%
Success rate
87.51%
Average return
Main Sectors:
Stocks Rated by Derik De Bruin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $116 → $110 | $97.06 | +13.33% | 3 | Jun 26, 2025 | |
| BRKR Bruker | Maintains: Buy | $61 → $50 | $41.29 | +21.09% | 13 | Jun 26, 2025 | |
| TXG 10x Genomics | Maintains: Neutral | $12 → $13 | $11.46 | +13.44% | 9 | Jun 26, 2025 | |
| QGEN Qiagen | Maintains: Buy | $50 → $53 | $47.56 | +11.44% | 6 | Jun 26, 2025 | |
| MTD Mettler-Toledo International | Maintains: Neutral | $1,200 → $1,260 | $1,183.29 | +6.48% | 10 | Jun 26, 2025 | |
| WAT Waters | Maintains: Neutral | $370 → $375 | $353.28 | +6.15% | 14 | Jun 26, 2025 | |
| A Agilent Technologies | Maintains: Neutral | $156 → $128 | $118.80 | +7.74% | 33 | Apr 14, 2025 | |
| MYGN Myriad Genetics | Maintains: Underperform | $13 → $11 | $5.18 | +112.36% | 13 | Mar 3, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $72 → $65 | $53.12 | +22.38% | 7 | Feb 20, 2025 | |
| NEO NeoGenomics | Maintains: Neutral | $19 → $16 | $7.08 | +125.99% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $675 → $660 | $408.78 | +61.46% | 18 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $255 → $235 | $156.82 | +49.85% | 3 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $220 → $210 | $149.58 | +40.40% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $355 | $217.96 | +62.87% | 7 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $26 | $24.59 | +5.73% | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $262 → $271 | $260.38 | +4.08% | 8 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $179 → $182 | $177.52 | +2.52% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $290 | $198.15 | +46.35% | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $13 → $15 | $25.43 | -41.01% | 4 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $26 → $21 | $5.01 | +319.16% | 5 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $32 | $20.24 | +58.10% | 1 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $140 → $100 | $94.23 | +6.12% | 11 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $94 → $86 | $64.97 | +32.37% | 11 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $13 | $4.17 | +211.75% | 1 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $9 → $6.5 | $2.11 | +208.79% | 1 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $265 → $260 | $144.34 | +80.13% | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $240 → $120 | $9.31 | +1,188.94% | 3 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $111 → $120 | $155.66 | -22.91% | 2 | Jul 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underperform | $10 → $9 | $1.51 | +498.01% | 7 | May 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $235 | $531.55 | -55.79% | 3 | Nov 2, 2018 |
Revvity
Jun 26, 2025
Maintains: Buy
Price Target: $116 → $110
Current: $97.06
Upside: +13.33%
Bruker
Jun 26, 2025
Maintains: Buy
Price Target: $61 → $50
Current: $41.29
Upside: +21.09%
10x Genomics
Jun 26, 2025
Maintains: Neutral
Price Target: $12 → $13
Current: $11.46
Upside: +13.44%
Qiagen
Jun 26, 2025
Maintains: Buy
Price Target: $50 → $53
Current: $47.56
Upside: +11.44%
Mettler-Toledo International
Jun 26, 2025
Maintains: Neutral
Price Target: $1,200 → $1,260
Current: $1,183.29
Upside: +6.48%
Waters
Jun 26, 2025
Maintains: Neutral
Price Target: $370 → $375
Current: $353.28
Upside: +6.15%
Agilent Technologies
Apr 14, 2025
Maintains: Neutral
Price Target: $156 → $128
Current: $118.80
Upside: +7.74%
Myriad Genetics
Mar 3, 2025
Maintains: Underperform
Price Target: $13 → $11
Current: $5.18
Upside: +112.36%
Exact Sciences
Feb 20, 2025
Maintains: Buy
Price Target: $72 → $65
Current: $53.12
Upside: +22.38%
NeoGenomics
Feb 19, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $7.08
Upside: +125.99%
Dec 13, 2024
Maintains: Buy
Price Target: $675 → $660
Current: $408.78
Upside: +61.46%
Dec 13, 2024
Maintains: Buy
Price Target: $255 → $235
Current: $156.82
Upside: +49.85%
Dec 13, 2024
Maintains: Neutral
Price Target: $220 → $210
Current: $149.58
Upside: +40.40%
Dec 13, 2024
Maintains: Buy
Price Target: $350 → $355
Current: $217.96
Upside: +62.87%
Dec 13, 2024
Maintains: Buy
Price Target: $24 → $26
Current: $24.59
Upside: +5.73%
Dec 13, 2024
Maintains: Buy
Price Target: $262 → $271
Current: $260.38
Upside: +4.08%
Dec 13, 2024
Maintains: Buy
Price Target: $179 → $182
Current: $177.52
Upside: +2.52%
Dec 13, 2024
Upgrades: Buy
Price Target: $290
Current: $198.15
Upside: +46.35%
Aug 30, 2024
Maintains: Underperform
Price Target: $13 → $15
Current: $25.43
Upside: -41.01%
Aug 13, 2024
Maintains: Underperform
Price Target: $26 → $21
Current: $5.01
Upside: +319.16%
Feb 29, 2024
Maintains: Neutral
Price Target: $38 → $32
Current: $20.24
Upside: +58.10%
Dec 12, 2023
Downgrades: Underperform
Price Target: $140 → $100
Current: $94.23
Upside: +6.12%
Aug 1, 2023
Maintains: Neutral
Price Target: $94 → $86
Current: $64.97
Upside: +32.37%
Jun 16, 2023
Downgrades: Neutral
Price Target: $13
Current: $4.17
Upside: +211.75%
Jan 4, 2023
Downgrades: Underperform
Price Target: $9 → $6.5
Current: $2.11
Upside: +208.79%
Nov 9, 2022
Upgrades: Buy
Price Target: $265 → $260
Current: $144.34
Upside: +80.13%
May 18, 2022
Downgrades: Underperform
Price Target: $240 → $120
Current: $9.31
Upside: +1,188.94%
Jul 1, 2019
Downgrades: Neutral
Price Target: $111 → $120
Current: $155.66
Upside: -22.91%
May 8, 2019
Reiterates: Underperform
Price Target: $10 → $9
Current: $1.51
Upside: +498.01%
Nov 2, 2018
Maintains: Buy
Price Target: $275 → $235
Current: $531.55
Upside: -55.79%